IXCHealth CareMergers & Acquisitions26 Oct 202626 October 2026· 2 min read
Invex Therapeutics (ASX: IXC) to Acquire Rekover and Raise $10 Million
Invex Therapeutics will acquire Rekover in an all-scrip deal and raise $10 million, adding the Phase 2a REVIVE multiple sclerosis study to its portfolio.